JN Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 95: 3286-3290, 2006; doi:10.1152/jn.00770.2005
0022-3077/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chin, J.
Right arrow Articles by Byrne, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chin, J.
Right arrow Articles by Byrne, J. H.

REPORT

TGF-beta1-Induced Long-Term Changes in Neuronal Excitability in Aplysia Sensory Neurons Depend on MAPK

Jeannie Chin1,*, Rong-Yu Liu1,*, Leonard J. Cleary1, Arnold Eskin2 and John H. Byrne1

1Department of Neurobiology and Anatomy, W. M. Keck Center for the Neurobiology of Learning and Memory, University of Texas Medical School at Houston; and 2Department of Biology and Biochemistry, University of Houston, Houston, Texas

Submitted 20 July 2005; accepted in final form 18 January 2006


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Transforming growth factor beta-1 (TGF-beta1) plays important roles in the early development of the nervous system and has been implicated in neuronal plasticity in adult organisms. It induces long-term increases in sensory neuron excitability in Aplysia as well as a long-term enhancement of synaptic efficacy at sensorimotor synapses. In addition, TGF-beta1 acutely regulates synapsin phosphorylation and reduces synaptic depression induced by low-frequency stimuli. Because of the critical role of MAPK in other forms of long-term plasticity in Aplysia, we examined the role of MAPK in TGF-beta1-induced long-term changes in neuronal excitability. Prolonged (6 h) exposure to TGF-beta1 induced long-term increases in excitability. We confirmed this finding and now report that exposure to TGF-beta1 was sufficient to activate MAPK and increase nuclear levels of active MAPK. Moreover, TGF-beta1 enhanced phosphorylation of the Aplysia transcriptional activator cAMP response element binding protein (CREB)1, a homologue to vertebrate CREB. Both the TGF-beta1-induced long-term changes in neuronal excitability and the phosphorylation of CREB1 were blocked in the presence of an inhibitor of the MAPK cascade, confirming a role for MAPK in long-term modulation of sensory neuron function.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Neurotrophins and cytokines are essential for the survival and differentiation of nerve cells, and they modulate synaptic transmission and neuronal plasticity in mature organisms. Neurotrophins have been studied extensively for their roles in modulating synaptic transmission in developing systems as well as adult animals (reviewed in Kojima et al. 2002Go; Lu 2003Go). A role for the cytokine TGF-beta1 in neuronal plasticity has also emerged. Recombinant TGF-beta1 induces long-term facilitation of Aplysia sensory-motor synapses (Zhang et al. 1997Go). Moreover, 5-HT-induced long-term facilitation is blocked by a soluble fragment of the TGF-beta1 type II receptor, which presumably acts by scavenging an endogenous TGF-beta1-like molecule. TGF-beta1 also induces long-term increases in neuronal excitability in Aplysia (Chin et al. 1999Go; Farr et al. 1999Go). Short-term modulation is also induced by TGF-beta1. Synaptic depression is reduced, in association with regulation of synapsin function (Chin et al. 2002Go). Finally, mice deficient in Smad, a component of the TGF-beta1 signaling pathway, have impaired spatial memory (Frankland et al. 2001Go).

The TGF-beta1 superfamily controls an array of cellular processes regulating development, growth, homeostasis, extracellular matrix production and regulation and wound repair (reviewed in Massagué, 1998Go; ten Dijke and Hill 2004). Recently, the regulation and roles of TGF-beta1 signaling in neurons have been investigated extensively (reviewed in Bottner et al. 2000Go; Sanyal et al. 2004Go). It has become clear that the pathways activated by TGF-beta1 in neurons overlap with those engaged by other factors that modulate neuronal and synaptic plasticity. Of particular interest are the MAPK pathway and the transcriptional activator cAMP response element binding protein (CREB), which have both been widely implicated for their roles in activity-dependent plasticity. TGF-beta1 transiently activates MAPK in chick ciliary ganglion neurons, which is necessary for acute and sustained effects of TGF-beta1 on KCa channel expression (Lhuillier and Dryer 2000Go). In addition, a number of studies have implicated MAPK as being an important mediator of TGF-beta1 signaling (reviewed in Mulder 2000Go). TGF-beta1 also activates the MAPK pathway in Aplysia sensory neurons, which is critical for the TGF-beta1-mediated reduction in synaptic depression at the sensorimotor synapse (Chin et al. 2002Go). The MAPK pathway plays a crucial role in the synaptic plasticity underlying learning and memory in both invertebrates and vertebrates (reviewed in Sweatt 2004Go). Among the targets of the MAPK pathway is the transcription factor CREB, which has been well-characterized for its role in long-term plasticity (reviewed in Lonze and Ginty 2002Go). CREB is also engaged by TGF-beta1 signaling (Liu et al. 2005Go; Warner et al. 2003Go; Zhang et al. 2004Go), representing a point of convergence between activity-dependent and neurotrophin/cytokine-dependent modulation of neuronal function. Of particular interest to the present study, long-term facilitation of Aplysia sensorimotor synapses induced by 5-HT involves the activation of MAPK and CREB1 (Bartsch et al. 1998Go; Martin et al. 1997Go; Michael et al. 1998Go; Purcell et al. 2003Go; Sharma et al. 2003Go).

In the present study, we demonstrate that TGF-beta1 induces the activation and increased nuclear localization of MAPK in sensory neurons and that this activation is necessary for TGF-beta1 to induce long-term changes in neuronal excitability. Moreover, the transcription factor CREB1 is activated by TGF-beta1 in a MAPK-dependent manner, suggesting that it may play a role in long-term changes induced by TGF-beta1. These results underscore the role of TGF-beta1 in modulating neuronal properties and the engagement of the MAPK/CREB signaling pathway in long-term neuronal plasticity.


    METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Culturing procedures followed those described in Shacher and Proshansky (1983)Go and Chin et al. (2002)Go. Mechanoafferent sensory neurons from the ventral-caudal cluster of the pleural ganglia were isolated and allowed to grow for 3–5 days at 18°C before experiments were begun. For immunocytochemistry, neurons were fixed in 4% paraformaldehyde in PBS containing 30% sucrose and incubated with anti-dually-phosphorylated MAPK (1:2500, Promega) or anti-phosphorylated CREB1 (1:1000) followed by tetramethylrhodamine-conjugated goat-anti-rabbit IgG. The anti-dually-phosphorylated MAPK antibody is specific for Aplysia MAPK (Fioravante et al. 2006Go). The rabbit polyclonal anti-phosphorylated-CREB1 (pCREB1) antibody was raised against Ser85-phosphorylated Aplysia CREB1 as previously described (Mohamed et al. 2005Go). Immunofluorescence was viewed with a confocal microscope (Biorad, MRC 1024MP). A z-series of optical sections through the cell body (0.25 µm increments) were taken, and the section through the middle of the nucleus was used for analysis of mean fluorescence intensities by means of ImageTool 2.1 software (Univ. of Texas Health Science Center at San Antonio). Eight to 10 neurons on each coverslip were analyzed, and measurements from neurons on the same coverslip were averaged. For electrophysiology, all recordings were performed at 22°C in solution containing 50% L15 and 50% ASW. Neurons were impaled with one microelectrode (resistance approximately 10 M{Omega}). Resting potential and input resistance were measured, and the neuron was held at –45 mV by passing current. Excitability was measured by counting the number of action potentials triggered by a 1-nA, 2-s depolarizing current pulse. Measurements from cells in one dish were averaged (2–3 cells per dish). After baseline measurements, cells were treated with TGF-beta1 (1 ng/ml), U0126 (20 µM in 0.2% DMSO, Promega), or 0.2% DMSO alone for 1 h prior to application of TGF-beta1 or BSA for 5 min (short-term experiments) or 6 h (long-term experiments). After the treatment, neurons were rinsed and returned to culture media. Excitability was assessed either 5 min later (short term) or 24 h later (long term). The individual performing the electrophysiological tests did not know which treatment the neurons had received.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Cultured sensory neurons exposed to 1 ng/ml TGF-beta1 for 6 h exhibited increased excitability measured 24 h later (Chin et al. 1999Go). Farr et al. (1999)Go also showed that TGF-beta1 increased the excitability of Aplysia sensory neurons measured 24 h after treatment. Moreover, injection of active MAPK into sensory neurons induced long-term increases in neuronal excitability (Sung et al. 2001Go). On the basis of the ability of both TGF-beta1 and MAPK to induce long-term changes in excitability, we examined whether MAPK activity was necessary for the long-term regulation of neuronal excitability by TGF-beta1. U0126, a specific inhibitor of MEK, an upstream activator of MAPK (Favata et al. 1998Go), inhibits the activation of MAPK in Aplysia sensory neurons (Chin et al. 2002Go). Using isolated sensory neurons grown in culture, we replicated our previous finding that TGF-beta1 increases neuronal excitability measured 24 h after 6 h treatment with TGF-beta1 (Chin et al. 1999Go). TGF-beta1 increased the excitability of neurons by 238 ± 30% (mean ± SE) of baseline (Fig. 1A1, n = 7, representing 18 neurons). However, the excitability of neurons treated with U0126 + TGF-beta1 was only 151 ± 24% of baseline (Fig. 1A2, n = 8, representing 20 neurons). The excitability of neurons treated with U0126 + BSA was 147 ± 13% (Fig. 1A3, n = 7, representing 18 neurons) indicating that the effect of U0126 + TGF-beta1 was the same as the effect of U0126 + BSA. A two-way analysis of variance (ANOVA), repeated measures design, revealed a significant difference among these three groups (F2,19 = 4.65, P < 0.05), and Tukey post hoc tests revealed that the group of neurons treated with DMSO + TGF-beta1 was significantly different from the other two groups. These results indicate that MAPK plays a critical role in the induction of long-term changes in excitability by TGF-beta1.


Figure 1
View larger version (12K):
[in this window]
[in a new window]
 
FIG. 1. TGF-beta1-induced long-term modulation of sensory neuron excitability requires MAPK activity. A: examples of spike trains evoked by current injection before (baseline) and 24 h after 6-h treatment with DMSO + TGF-beta1 (A1), MEK inhibitor U0126 + TGF-beta1 (A2) or DMSO + BSA (A3). B: summary data. Inhibition of MAPK blocked the ability of TGF-beta1 to induce a long-term increase in sensory neuron excitability (P < 0.05, two-way ANOVA, repeated measures). Tukey post hoc test indicated that the DMSO+TGF-beta1 group is significantly different from the other two groups. In this and subsequent illustrations, asterisk denotes P < 0.05.

 
Because TGF-beta1 acutely stimulates MAPK activation in sensory neurons (Chin et al. 2002Go), we examined whether acute (5 min) exposure to TGF-beta1 was sufficient to induce short-term changes in excitability. These experiments were performed in a manner identical to that described above, but the excitability of sensory neurons was immediately retested after the end of the 5 min treatment with TGF-beta1. Five minutes of treatment with TGF-beta1 did not alter sensory neuron excitability (111 ± 17%, mean ± SE, for TGF-beta1 vs. 95 ± 11% for BSA, n = 8, t14 = 0.81, P = 0.43). We also examined whether the brief, 5-min treatment would induce the long-term increase in neuronal excitability. Twenty-four hours after the 5-min treatment, the excitability of the sensory neurons was not different from that of BSA-treated controls (149 ± 27%, mean ± SE, for TGF-beta1 vs. 146 ± 24% for BSA, n = 4, t6 = 0.89, P = 0.41).

On MAPK phosphorylation and activation, a portion of the active MAPK pool translocates to the nucleus to modulate transcription factor targets (reviewed in Chang and Karin 2001Go). Stimuli that induce many forms of long-term neuronal and synaptic plasticity stimulate MAPK activation and lead to increased nuclear levels of active MAPK. Because we and others have shown that TGF-beta1 induces long-term forms of neuronal plasticity, we examined whether TGF-beta1 increased nuclear levels of active MAPK. We previously showed that TGF-beta1 quickly (within 5 min) activates MAPK in an MEK-dependent manner (Chin et al. 2002Go), but we did not know whether activation represented increased nuclear levels of active MAPK. Although we observed the electrophysiological effects of TGF-beta1 observed only after prolonged treatment (Fig. 1), we hypothesized that transcriptional events necessary for these long-term effects are initiated earlier. Therefore we treated cultured neurons with TGF-beta1 for 5 min, 30 min, or 6 h and then processed the neurons for immunofluorescence staining. Neurons treated with TGF-beta1 for 5 min and 30 min exhibited higher levels of dually phosphorylated MAPK in both nuclear and cytoplasmic compartments compared with BSA-treated control neurons (Fig. 2, A and B). Nuclear staining was increased by 21 ± 3% (mean ± SE) after 5 min treatment with TGF-beta1 (n = 3, representing 32 BSA-treated neurons and 30 TGF-beta1–treated neurons, t2 = 6.57, P < 0.05) and by 25 ± 12% after 30 min treatment (n = 4, representing 25 BSA-treated neurons and 23 TGF-beta1–treated neurons, t3 = 2.8, P < 0.05). TGF-beta1 also increased cytoplasmic staining by 10 ± 2% (mean ± SE) after 5 min (t2 = 3.91, P < 0.05), and there was a trend for an increase after 30 min (20 ± 12%, t3 = 2.03, P = 0.067). By 6 h of TGF-beta1 treatment, both nuclear and cytoplasmic MAPK were back to basal levels. These findings indicate that, as predicted, TGF-beta1 rapidly activates MAPK and increases nuclear levels of active MAPK. This translocation of activated MAPK is sustained for ≥30 min, consistent with the hypothesis that there is a temporal threshold required to induce transcriptional events necessary to induce long-term changes in neuronal excitability.


Figure 2
View larger version (16K):
[in this window]
[in a new window]
 
FIG. 2. TGF-beta1 increases nuclear levels of active MAPK in sensory neurons. A: optical sections imaged from neurons treated for 5 min with either TGF-beta1 or BSA. B: summary data indicates a significant increase in phospho-MAPK immunoreactivity in the nucleus of TGF-beta1–treated neurons as compared with controls after 5 min and 30 min treatment with TGF-beta1. Phospho-MAPK immunoreactivity is back to basal levels after 6 h TGF-beta1 treatment.

 
The transcription factor CREB is critical for regulating transcriptional events in the induction of long-term synaptic plasticity in Aplysia as well as in other model systems (reviewed in Lonze and Ginty 2002Go). In many systems, the MAPK pathway, including intermediates such as RSK1, leads to phosphorylation and activation of CREB and promotes its ability to activate transcription (Hardingham et al. 2001Go; Wu et al. 2001Go). The initiation of transcriptional events by CREB1, the Aplysia isoform of CREB, is negatively regulated by CREB2, the Aplysia isoform of the transcriptional repressor ATF1 (reviewed in Kandel 2001Go). To determine whether CREB1 may play a role in TGF-beta1-induced long-term neuronal plasticity, we examined whether TGF-beta1 treatment resulted in CREB1 phosphorylation and increased nuclear staining. We found that whereas 5 min treatment with TGF-beta1 was not sufficient to significantly increase nuclear phospho-CREB1 staining (1 ± 8%, mean ± SE; n = 4, representing 23 BSA-treated and 20 TGF-beta1–treated neurons, t3 = 0.34, P = 0.38), 30 min treatment with TGF-beta1 significantly increased nuclear phospho-CREB1 staining (15 ± 4%, n = 4, representing 20 BSA-treated and 18 TGF-beta1–treated neurons, t3 = 3.24, P < 0.05). TGF-beta1-induced increases in nuclear phospho-CREB1 levels were dependent on the MAPK pathway, as we found that the increase in nuclear phospho-CREB1 was blocked with U0126 even when induced by a higher concentration (10 ng/ml) of TGF-beta1 (33 ± 10%, mean ± SE, increase in TGF-beta1–treated vs. 2 ± 6% increase in U0126+TGF-beta1–treated neurons, n = 5, representing 41 DMSO+BSA-treated, 42 DMSO+TGF-beta1–treated, 42 U0126+BSA-treated and 47 U0126+TGF-beta1–treated neurons). ANOVA revealed a significant effect of treatment between the three groups, and Tukey post hoc tests revealed that the group of neurons treated with DMSO + TGF-beta1 was significantly different from the other two groups (F2,12 = 5.00, P < 0.05, Fig. 3C).


Figure 3
View larger version (18K):
[in this window]
[in a new window]
 
FIG. 3. TGF-beta1 increases levels of nuclear phospho-CREB1 in sensory neurons. A: optical sections imaged from neurons treated for 30 min with either TGF-beta1 or BSA. B: summary data indicates that 5 min treatment with TGF-beta1 does not affect nuclear phospho-CREB1 levels, whereas 30 min treatment with TGF-beta1 significantly increases nuclear levels of phospho-CREB1. C: the increase in nuclear phospho-CREB1 induced by 10 ng/ml TGF-beta1 is blocked by pretreatment with U0126.

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
MAPK is both necessary (Fig. 1) and sufficient (Sung et al. 2001Go) for the induction of long-term changes in the excitability of sensory neurons by TGF-beta1. Moreover, TGF-beta1 leads to an activation of MAPK in sensory neurons (Fig. 2 and Chin et al. 2002Go) and results in increased nuclear levels of active MAPK (Fig. 2). The rapid activation of MAPK by TGF-beta1 is in contrast to a much slower activation by 5-HT, with undetectable activation at the end of a 5-min pulse of 5-HT and a graded activation/translocation with additional pulses of 5-HT (Martin et al. 1997Go; Michael et al. 1998Go; Sharma et al. 2003Go). Although a 5-min treatment of TGF-beta1 was sufficient to activate MAPK and cause an increase in nuclear levels of activated MAPK (Fig. 2), a 6-h treatment was necessary to induce a long-term change in excitability (Fig. 1). Presumably, at some point during the 6-h treatment, levels of activated MAPK became sufficient to activate gene expression necessary for long-term changes in excitability. This hypothesis is supported by our finding that whereas 5 min treatment with TGF-beta1 did not increase nuclear levels of phospho-CREB1, 30 min treatment with TGF-beta1 did increase nuclear levels of phospho-CREB1 in a MAPK-dependent manner. Such an increase in nuclear phospho-CREB1 suggests that ≥30 min of TGF-beta1 treatment is necessary to induce the transcriptional events necessary for long-term increases in neuronal excitability. By 6 h of TGF-beta1 treatment, events necessary for long-term changes in excitability have been achieved, and active MAPK levels are back to basal levels.

The intermediate steps between the activation of the TGF-beta1 receptor and the activation of MAPK are not known. The most likely possibility is that the activated receptor leads directly to the activation of MAPK through Ras (Derynk and Zhang 2003Go). However, PKC is also known to couple to the MAPK pathway (reviewed in Sweatt 2004Go). An alternative possibility that needs to be examined is that TGF-beta1 engages the PKC cascade. PKC is activated by TGF-beta1 (Farr et al. 1999Go) and induces long-term changes in sensory neuron excitability (Manseau et al. 1998Go), and at least one MAPK-dependent protein phosphorylation in Aplysia is blocked by a PKC inhibitor (Yamamoto et al. 1999Go).

The neurotrophins have been well characterized for their roles in development as well as in adult organisms (Kojima et al. 2002Go; Lu 2003Go; Tyler et al. 2002Go). Although each of these growth factors can have distinct effects in neuronal plasticity, one common factor in the signaling mechanisms of both neurotrophins and cytokines seems to be the engagement of the MAPK pathway. Our results implicating MAPK in TGF-beta1-induced long-term changes in sensory neuron excitability in Aplysia add to this body of evidence. In addition, the present results provide a starting point from which to begin examining the substrate proteins such as CREB1 that are the targets of MAPK-dependent phosphorylation and the ways those proteins lead to the induction and expression of long-term changes induced by TGF-beta.


    GRANTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
This work was supported by National Institute of Neurological Disorders and Stroke Grants NS-38100 to L. J. Cleary, NS-28462 to A. Eskin, and NS-19895 to J. H. Byrne.


    ACKNOWLEDGMENTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Present address of J. Chin: Gladstone Institute of Neurological Disease, University of California San Francisco, 1650 Owens St, San Francisco, CA 94158.


    FOOTNOTES
 
* J. Chin and R-Y. Liu contributed equally to this work. Back

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Address for reprint requests and other correspondence: J. H. Byrne, Department of Neurobiology and Anatomy, University of Texas-Houston Medical School, Houston, Texas 77030 (E-mail: john.h.byrne{at}uth.tmc.edu)


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Axmann A, Seidel D, Reimann T, Hempel U, and Wenzel KW. Transforming growth factor-beta1-induced activation of the Raf-MEK-MAPK signaling pathway in rat lung fibroblasts via a PKC-dependent mechanism. Biochem Biophys Res Commun 249: 456–460, 1998.[CrossRef][ISI][Medline]

Bartsch D, Casadio A, Karl K, Serodio P, and Kandel ER. CREB1 encodes a nuclear activator, a repressor, and a cytoplasmic modulator that form a regulatory unit critical for long-term facilitation. Cell 95: 211–223, 1998.[CrossRef][ISI][Medline]

Bottner M, Krieglstein K, and Unsicker K. The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions. J Neurochem 75(6): 2227–40, 2000.[CrossRef][ISI][Medline]

Chang L and Karin M. Mammalian MAP kinase signaling cascades. Nature 410: 37–40, 2001.[CrossRef][Medline]

Chin J, Angers A, Cleary LJ, Eskin A, and Byrne JH. TGF-beta1 in Aplysia: role in long-term changes in the excitability of sensory neurons and distribution of TbetaR-II-like immunoreactivity. Learn Mem 6: 317–330, 1999.[Abstract/Free Full Text]

Chin J, Angers A, Cleary LJ, Eskin A, and Byrne JH. TGF-beta1 alters synapsin distribution and reduces synaptic depression in Aplysia. J Neurosci 22(RC220): 1–6, 2002.[Abstract/Free Full Text]

Derynck R and Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signaling. Nature 425: 577–584, 2003.[CrossRef][Medline]

Farr M, Mathews J, Zhu DF, and Ambron RT. Inflammation causes a long-term hyperexcitability in the nociceptive sensory neurons of Aplysia. Learn Mem 6: 331–340, 1999.[Abstract/Free Full Text]

Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, and Trzaskos JM. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273: 18623–18632, 1998.[Abstract/Free Full Text]

Fioravante D, Smolen PD, and Byrne JH The 5-HT- and FMRFa-activated signaling pathways interact at the level of the Erk MAPK cascade: Potential inhibitory constraints on memory formation. Neuroscience Letters (in press). (2006)

Frankland PW, Wang Y, Heyer J, Kucherlapati R, and Silva A. A role for TGFbeta signaling in spatial learning and memory. Soc Neurosci Abstr 27: 1980, 2001.

Hardingham GE, Arnold FJ, and Bading H. A calcium microdomain near NMDA receptors: on switch for ERK-dependent synapse-to-nucleus communication. Nat Neurosci 4: 565–566, 2001.[CrossRef][ISI][Medline]

Kandel ER. The molecular biology of memory storage: a dialogue between genes and synapses. Science 294(5544): 1030–1038, 2001.[Abstract/Free Full Text]

Kojima M, Klein RL, and Hatanaka H. Pre- and post-synaptic modification by neurotrophins. Neurosci Res 43(3): 193–199, 2002.[CrossRef][ISI][Medline]

Lhuillier L and Dryer SE. Developmental regulation of neuronal KCa channels by TGFbeta1: transcriptional and posttranscriptional effects mediated by Erk MAP kinase. J Neurosci 20: 5616–5622, 2000.[Abstract/Free Full Text]

Liu R, Fukushima T, and Byrne JH Transforming growth factor beta2 (TGF-beta2) induces phosphorylation of CREB and produces long-term facilitation of synaptic currents in rat hippocampal neurons. Soc Neurosci Abstr 503.12. (2005)

Lonze BE and Ginty DD. Function and regulation of CREB family transcription factors in the nervous system. Neuron 34(4): 605–623, 2002.

Lu B. BDNF and activity-dependent synaptic modulation. Learn Mem 10(2): 86–98, 2003.[Abstract/Free Full Text]

Manseau F, Sossin WS, and Castellucci VF. Long-term changes in excitability induced by protein kinase C activation in Aplysia sensory neurons. J Neurophysiol 79: 1210–1218, 1998.[Abstract/Free Full Text]

Martin KC, Michael D, Rose JC, Barad M, Casadio A, Zhu H, and Kandel ER. MAP kinase translocates into the nucleus of the presynaptic cell and is required for long-term facilitation in Aplysia. Neuron 18: 899–912, 1997.[CrossRef][ISI][Medline]

Massague J. TGF-beta signal transduction. Annu Rev Biochem 67: 753–791, 1998.[CrossRef][ISI][Medline]

Michael D, Martin KC, Seger R, Ning MM, Baston R, and Kandel ER. Repeated pulses of serotonin required for long-term facilitation activate mitogen-activated protein kinase in sensory neurons of Aplysia. Proc Natl Acad Sci USA 95: 1864–1869, 1998.[Abstract/Free Full Text]

Mohamed HA, Yao W, Fioravante D, Smolen P, and Byrne JH. cAMP-response elements in Aplysia creb1, creb2, and Ap-uch promoters: implications for feedback loops modulating long term memory. J Biol Chem 280: 27035–27043, 2005.[Abstract/Free Full Text]

Mulder KM. Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev 11: 23–35, 2000.[CrossRef][ISI][Medline]

Purcell AL, Sharma SK, Bagnall MW, Sutton MA, and Carew TJ. Activation of a tyrosine kinase-MAPK cascade enhances the induction of long-term synaptic facilitation and long-term memory in Aplysia. Neuron 37: 473–84, 2003.[CrossRef][ISI][Medline]

Sanyal S, Kim SM, and Ramaswami M. Retrograde regulation in the CNS: neuron-specific interpretations of TGF-beta signaling. Neuron 41: 845–848, 2004.[CrossRef][ISI][Medline]

Schacher S and Proshansky E. Neurite regeneration by Aplysia neurons in dissociated cell culture: modulation by Aplysia hemolymph and the presence of the initial axonal segment. J Neurosci 3: 2403–2413, 1983.[Abstract]

Sharma K, Sherff CM, Shobe J, Bagnall MW, Sutton MA, and Carew TJ. Differential roles of mitogen-activated protein kinase in three distinct phases of memory for sensitization in Aplysia. J Neurosci 23: 3899–907, 2003.

Sharma K and Carew TJ. The roles of MAPK cascades in synaptic plasticity and memory in Aplysia: facilitatory effects and inhibitory constraints. Learn Mem 11: 373–378, 2004.[Abstract/Free Full Text]

Sung YJ, Povelones M, and Ambron RT. RISK-1: a novel MAPK homologue in axoplasm that is activated and retrogradely transported after nerve injury. J Neurobiol 47: 67–79, 2001.[CrossRef][ISI][Medline]

Sweatt JD. Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 14(3): 311–317, 2004.[CrossRef][ISI][Medline]

ten Dijke P, and Hill CS. New insights into TGF-beta-Smad signalling. Trends Biochem Sci 29(5): 265–273, 2004.[CrossRef][ISI][Medline]

Tyler WJ, Perrett SP, and Pozzo-Miller LD The role of neurotrophins in neurotransmitter release. Neuroscientist 8(6): 524–531. (2002)[CrossRef][ISI][Medline]

Warner DR, Pisano MM, and Greene RM. Nuclear convergence of the TGFbeta and cAMP signal transduction pathways in murine embryonic palate mesenchymal cells. Cell Signal 15: 235–242, 2003.[CrossRef][ISI][Medline]

Wu GY, Deisseroth K, and Tsien RW. Activity-dependent CREB phosphorylation: convergence of a fast, sensitive calmodulin kinase pathway and a slow, less sensitive mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 98: 2808–2813, 2001.[Abstract/Free Full Text]

Yamamoto N, Hegde AN, Chain DG, and Schwartz JH. Activation and degradation of the transcription factor C/EBP during long-term facilitation in Aplysia. J Neurochem 73: 2415–2423, 1999.[CrossRef][ISI][Medline]

Zhang F, Endo S, Cleary LJ, Eskin A, and Byrne JH. Role of transforming growth factor-beta in long-term synaptic facilitation in Aplysia. Science 275: 1318–1320, 1997.[Abstract/Free Full Text]

Zhang L, Duan CJ, Binkley C, Li G, Uhler MD, Logsdon CD, and Simeone DM. A transforming growth factor beta-induced Smad3/Smad4 complex directly activates protein kinase A. Mol Cell Biol 24: 2169–2180, 2004.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
J. Neurosci.Home page
M. Sun, M. J. Thomas, R. Herder, M. L. Bofenkamp, S. B. Selleck, and M. B. O'Connor
Presynaptic Contributions of Chordin to Hippocampal Plasticity and Spatial Learning
J. Neurosci., July 18, 2007; 27(29): 7740 - 7750.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chin, J.
Right arrow Articles by Byrne, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chin, J.
Right arrow Articles by Byrne, J. H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the The American Physiological Society.